Logo image of ALESE.PA

ENTECH SACA (ALESE.PA) Stock Fundamental Analysis

EPA:ALESE - Euronext Paris - Matif - FR0014004362 - Common Stock - Currency: EUR

7.48  -0.26 (-3.36%)

Fundamental Rating

4

Overall ALESE gets a fundamental rating of 4 out of 10. We evaluated ALESE against 40 industry peers in the Construction & Engineering industry. ALESE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALESE is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALESE has reported negative net income.
In the past year ALESE has reported a negative cash flow from operations.
In the past 5 years ALESE reported 4 times negative net income.
ALESE had a negative operating cash flow in each of the past 5 years.
ALESE.PA Yearly Net Income VS EBIT VS OCF VS FCFALESE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -2M -4M -6M -8M -10M

1.2 Ratios

ALESE has a Return On Assets of -1.53%. This is amonst the worse of the industry: ALESE underperforms 87.50% of its industry peers.
ALESE has a worse Return On Equity (-3.00%) than 85.00% of its industry peers.
Industry RankSector Rank
ROA -1.53%
ROE -3%
ROIC N/A
ROA(3y)-2.33%
ROA(5y)-0.87%
ROE(3y)-4.85%
ROE(5y)-2.97%
ROIC(3y)N/A
ROIC(5y)N/A
ALESE.PA Yearly ROA, ROE, ROICALESE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

ALESE has a better Gross Margin (48.83%) than 62.50% of its industry peers.
ALESE's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ALESE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 48.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.07%
GM growth 5YN/A
ALESE.PA Yearly Profit, Operating, Gross MarginsALESE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

5

2. Health

2.1 Basic Checks

ALESE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALESE remains at a similar level compared to 1 year ago.
ALESE has a worse debt/assets ratio than last year.
ALESE.PA Yearly Shares OutstandingALESE.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M
ALESE.PA Yearly Total Debt VS Total AssetsALESE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

ALESE has an Altman-Z score of 4.15. This indicates that ALESE is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 4.15, ALESE belongs to the best of the industry, outperforming 92.50% of the companies in the same industry.
A Debt/Equity ratio of 0.08 indicates that ALESE is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.08, ALESE belongs to the best of the industry, outperforming 92.50% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z 4.15
ROIC/WACCN/A
WACC7.55%
ALESE.PA Yearly LT Debt VS Equity VS FCFALESE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 1.94 indicates that ALESE should not have too much problems paying its short term obligations.
ALESE has a better Current ratio (1.94) than 82.50% of its industry peers.
ALESE has a Quick Ratio of 1.81. This is a normal value and indicates that ALESE is financially healthy and should not expect problems in meeting its short term obligations.
ALESE has a Quick ratio of 1.81. This is amongst the best in the industry. ALESE outperforms 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.94
Quick Ratio 1.81
ALESE.PA Yearly Current Assets VS Current LiabilitesALESE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 73.07% over the past year.
The Revenue has grown by 35.96% in the past year. This is a very strong growth!
The Revenue has been growing by 68.95% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)73.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.33%
Revenue 1Y (TTM)35.96%
Revenue growth 3Y68.95%
Revenue growth 5YN/A
Sales Q2Q%43.81%

3.2 Future

ALESE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 116.80% yearly.
Based on estimates for the next years, ALESE will show a very strong growth in Revenue. The Revenue will grow by 35.69% on average per year.
EPS Next Y123.81%
EPS Next 2Y160.95%
EPS Next 3Y116.8%
EPS Next 5YN/A
Revenue Next Year42.47%
Revenue Next 2Y51.97%
Revenue Next 3Y32.1%
Revenue Next 5Y35.69%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ALESE.PA Yearly Revenue VS EstimatesALESE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M
ALESE.PA Yearly EPS VS EstimatesALESE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.2 0.4 0.6 0.8

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

ALESE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
ALESE is valuated correctly with a Price/Forward Earnings ratio of 14.38.
Based on the Price/Forward Earnings ratio, ALESE is valued a bit more expensive than the industry average as 60.00% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, ALESE is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 14.38
ALESE.PA Price Earnings VS Forward Price EarningsALESE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALESE is valued a bit more expensive than 75.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 228.87
ALESE.PA Per share dataALESE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

ALESE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALESE's earnings are expected to grow with 116.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y160.95%
EPS Next 3Y116.8%

More info and screens

0

5. Dividend

5.1 Amount

ALESE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ENTECH SACA

EPA:ALESE (3/7/2025, 7:00:00 PM)

7.48

-0.26 (-3.36%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners11.95%
Inst Owner ChangeN/A
Ins Owners63.72%
Ins Owner ChangeN/A
Market Cap109.81M
Analysts86
Price Target11.27 (50.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-72.22%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)9.69%
Revenue NY rev (3m)0.69%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 14.38
P/S 2.07
P/FCF N/A
P/OCF N/A
P/B 4.27
P/tB 5.54
EV/EBITDA 228.87
EPS(TTM)-0.05
EYN/A
EPS(NY)0.52
Fwd EY6.95%
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS3.62
BVpS1.75
TBVpS1.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.53%
ROE -3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 48.83%
FCFM N/A
ROA(3y)-2.33%
ROA(5y)-0.87%
ROE(3y)-4.85%
ROE(5y)-2.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.07%
GM growth 5YN/A
F-Score5
Asset Turnover1.06
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA 4.3
Cap/Depr 243.28%
Cap/Sales 6.22%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.94
Quick Ratio 1.81
Altman-Z 4.15
F-Score5
WACC7.55%
ROIC/WACCN/A
Cap/Depr(3y)285.26%
Cap/Depr(5y)212.15%
Cap/Sales(3y)7.1%
Cap/Sales(5y)9.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)73.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.33%
EPS Next Y123.81%
EPS Next 2Y160.95%
EPS Next 3Y116.8%
EPS Next 5YN/A
Revenue 1Y (TTM)35.96%
Revenue growth 3Y68.95%
Revenue growth 5YN/A
Sales Q2Q%43.81%
Revenue Next Year42.47%
Revenue Next 2Y51.97%
Revenue Next 3Y32.1%
Revenue Next 5Y35.69%
EBIT growth 1Y72.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year277.14%
EBIT Next 3Y119.77%
EBIT Next 5Y97.66%
FCF growth 1Y65.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y98.14%
OCF growth 3YN/A
OCF growth 5YN/A